Gilbert Lynn Marks

Companies

• AN2 Therapeutics, Inc.Board member Mar 24, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAN2 Therapeutics, Inc. ANTX81,873 shares²$267.7K at $3.27Jul 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 10, 2026Granted 2,789 shares of AN2 Therapeutics, Inc.²
• Apr 10, 2026Granted 3,775 shares of AN2 Therapeutics, Inc.³
• Jan 12, 2026Granted 11,560 shares of AN2 Therapeutics, Inc.⁴
• Oct 10, 2025Granted 10,367 shares of AN2 Therapeutics, Inc.⁵
• Jul 10, 2025Granted 11,875 shares of AN2 Therapeutics, Inc.⁶
• Apr 10, 2025Granted 9,705 shares of AN2 Therapeutics, Inc.⁷
• Dec 19, 2024Granted 8,972 shares of AN2 Therapeutics, Inc.⁸